CTRC-Austin

Clinical Trials Research Center (CTRC) is a premier clinical research site located in Austin, Texas, that specializes in conducting Phase I through IV clinical trials. Founded in 1994, the center has established itself as a leader in therapeutic areas such as endocrinology, hepatology, infectious diseases, and women's health. In January 2022, CTRC was acquired by Velocity Clinical Research, integrating the facility into one of the world's largest networks of fully integrated clinical site organizations. The center is particularly recognized for its expertise in complex metabolic studies, including those for Type 2 diabetes and nonalcoholic steatohepatitis (NASH). CTRC provides comprehensive trial management, rapid patient recruitment, and high-quality data services to global pharmaceutical and biotechnology sponsors. The facility continues to operate as a key hub for clinical innovation in the Southwest United States under the Velocity brand.